Maureen Franco

Maureen Franco is an accomplished professional in corporate communications and marketing within the biopharma industry, currently serving as the VP of Corporate Communications at Edgewise Therapeutics since October 2023. Previously, Maureen co-founded and led PRE Commercial as CEO, focusing exclusively on pre-commercial biopharma marketing consulting. Maureen has held significant roles including President at LifeSci Communications, where organizational transformation took place, and CEO at Cambridge BioMarketing, where Maureen drove extensive growth and established the agency as a leader in the rare disease sector. Earlier in Maureen's career, roles included VP positions at Sanofi and Genzyme Therapeutics, where commercial strategies were developed across various divisions. Maureen holds a Bachelor of Science from Boston College and has completed the Strategic Marketing and Management Executive Program at Stanford University Graduate School of Business.